fig5

Curcumin sensitizes quiescent leukemic cells to antimitotic drug 5-fluorouracil by inducing proliferative responses in them

Figure 5. Cell cycle analysis showing that curcumin causes greater migration of QLCs from the G0/G1 phase to other stages of the cell cycle: QLCs were treated with curcumin (10 µg/mL) for 48 h. After 48 h the quiescent cells were incubated with 5-FU (6 µg/mL) for another 24 h and then subjected to PI staining. The stained cells were acquired and analyzed using BD FACSCaliburTM. As compared to the vehicle control (VC), a much higher percentage of cells treated with curcumin were pushed into the S and G2/M phase. More importantly, the QLCs that were exposed to curcumin were more effectively killed by 5-FU than cells that were not. (A) Side scatter plot of untreated vehicle control cells (QLCs), where R1 is the gated population of QLCs that is positive for PI. The histograms demonstrate a distinct pattern of the different phases of the cell cycle marked as M1 (G1/G0 phase), M2 (S-phase), M3 (G2/M phase) and M4 (Dead cells) of untreated QLCs (VC) and of QLCs subjected to curcumin and/or 5-FU treatments; (B) a tabular and graphical representation of , depicting the percentage of gated QLCs in each stage of the cell cycle in response to treatment with cucrumin and/or 5-FU

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/